Eikon Therapeutics Announces Clearance to Proceed with First-in-Human Phase 1/2 Study for Novel Androgen Receptor Antagonist EIK1006 in Advanced Metastatic Prostate Cancer
MILLBRAE, Calif., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced U.S. Food and Drug Administration clearance to proceed for the Investigational New Drug (IND) application to evaluate EIK1006 for the treatment of advanced metastatic prostate cancer.
MILLBRAE, Calif., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced U.S. Food and Drug Administration clearance to proceed for the Investigational New Drug (IND) application to evaluate EIK1006 for the treatment of advanced metastatic prostate cancer.
Cribl positioned highest in Ability to Execute and furthest in Completeness of Vision in the first Gartner evaluation of the market Cribl positioned highest in Ability to Execute and furthest in Completeness of Vision in the first Gartner evaluation of the market ...
Investors in Duolingo, Inc., Webull Corporation, The Ensign Group, Inc., and Netcapital Inc. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions Investors in Duolingo, Inc., Webull Corporation, The Ensign Group, Inc., and Netcapital Inc. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions ...
Collaboration Brings AI-Enhanced MFT to the Public Sector for Secure, Governed Data Movement Collaboration Brings AI-Enhanced MFT to the Public Sector for Secure, Governed Data Movement ...
NEW YORK, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Museum think tank Remuseum, in partnership with the Doris Duke Foundation, announces the inaugural class of awardees for The Vanguard: a first-of-its-kind incubator for innovative leaders in the visual and performing arts. Awardees’ organizations will each receive a $100,000 investment to carry out a new idea, and commit… ...